Is interferon effective and safe for relapsing-remitting multiple sclerosis?

Neuroepidemiology

Volumn 21, Issue 6, 2002, Pages 310-

  Filippini, Graziella ^a   Incorvaia, Barbara ^b  

^a Dipartimento di Scienze Neurologiche   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA1A INTERFERON; INTERFERON; INTERFERON BETA SERINE;

CLINICAL TRIAL; COCHRANE LIBRARY; DISABILITY; DISEASE COURSE; DISEASE EXACERBATION; DRUG EFFICACY; DRUG SAFETY; DRUG SELF ADMINISTRATION; EMBASE; EUROPE; FLU LIKE SYNDROME; FOLLOW UP; HEALTH STATUS; HUMAN; METHODOLOGY; MULTIPLE SCLEROSIS; NOTE; OUTCOMES RESEARCH; QUALITY CONTROL; RATING SCALE; RELAPSE; REMISSION; RISK BENEFIT ANALYSIS; TREATMENT OUTCOME; UNITED STATES;

EID: 0036968181     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000065530     Document Type: Note

References (1)

1. Rice G, Incorvaia B, Munari L, Ebers G, Polman C, D'Amico R, Filippini G: Interferon in relapsing-remitting multiple sclerosis; in: Cochrane Library, Issue 4, 2001. Update Software.